These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cryoglobulinemia with acronecrosis not associated with hepatitis C infection: a case report. Ramírez Huaranga MA; Ramos Rodríguez CC; Bellido Pastrana D Reumatol Clin; 2012; 8(2):84-6. PubMed ID: 22089061 [TBL] [Abstract][Full Text] [Related]
9. B-cell depletion in the treatment of mixed cryoglobulinemia. Sansonno D; Tucci FA; Montrone M; Troiani L; Sansonno L; Gatti P; Lauletta G Dig Liver Dis; 2007 Sep; 39 Suppl 1():S116-21. PubMed ID: 17936212 [TBL] [Abstract][Full Text] [Related]
10. Rituximab for the treatment of glomerulonephritis in hepatitis C associated cryoglobulinaemia. Korte MR; van Heerde MJ; de Man RA; Betjes MH Neth J Med; 2008 Jan; 66(1):27-30. PubMed ID: 18219065 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Zaja F; De Vita S; Mazzaro C; Sacco S; Damiani D; De Marchi G; Michelutti A; Baccarani M; Fanin R; Ferraccioli G Blood; 2003 May; 101(10):3827-34. PubMed ID: 12560225 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus-related cryoglobulinemia and glomerulonephritis: pathogenesis and therapeutic strategies. Garini G; Allegri L; Vaglio A; Buzio C Ann Ital Med Int; 2005; 20(2):71-80. PubMed ID: 16052839 [TBL] [Abstract][Full Text] [Related]
14. [Recent advances in the treatment of HCV cryoglobulinemia vasculitis]. Cacoub P Presse Med; 2011 Nov; 40(11):991-4. PubMed ID: 21664794 [No Abstract] [Full Text] [Related]
15. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. De Vita S; Quartuccio L; Isola M; Mazzaro C; Scaini P; Lenzi M; Campanini M; Naclerio C; Tavoni A; Pietrogrande M; Ferri C; Mascia MT; Masolini P; Zabotti A; Maset M; Roccatello D; Zignego AL; Pioltelli P; Gabrielli A; Filippini D; Perrella O; Migliaresi S; Galli M; Bombardieri S; Monti G Arthritis Rheum; 2012 Mar; 64(3):843-53. PubMed ID: 22147661 [TBL] [Abstract][Full Text] [Related]
16. Cryoglobulinaemia: clinical features and response to treatment. Singer DR; Venning MC; Lockwood CM; Pusey CD Ann Med Interne (Paris); 1986; 137(3):251-3. PubMed ID: 3767196 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and risk of rituximab in type II mixed cryoglobulinemia: a significant case report. Massari M; Catania A; Magnani G Dig Liver Dis; 2007 Sep; 39 Suppl 1():S134-5. PubMed ID: 17936216 [No Abstract] [Full Text] [Related]
18. Expert opinion on managing chronic HCV in patients with mixed cryoglobulinaemia vasculitis. Zignego AL; Pawlotsky JM; Bondin M; Cacoub P Antivir Ther; 2018; 23(Suppl 2):1-9. PubMed ID: 30451151 [TBL] [Abstract][Full Text] [Related]
19. Cryoglobulinemia vasculitis: how to handle. Desbois AC; Comarmond C; Saadoun D; Cacoub P Curr Opin Rheumatol; 2017 Jul; 29(4):343-347. PubMed ID: 28368978 [TBL] [Abstract][Full Text] [Related]
20. [Central nervous system involvement in patients with HCV-related cryoglobulinemia: literature review and a case report]. Filippini D; Colombo F; Jann S; Cornero R; Canesi B Reumatismo; 2002; 54(2):150-5. PubMed ID: 12105684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]